Feedback / Questions
nintedanib inhaled (AP02) - Avalyn Pharma
https://www.globenewswire.com/news-release/2025/09/15/3149935/0/en/Avalyn-to-Highlight-AURA-IPF-Phase-2-Clinical-Trial-Design-for-AP02-Inhaled-Nintedanib-at-the-European-Respiratory-Society-International-Congress-2025.html
Sep 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next